Related Experiment Video
Updated: Jun 7, 2025

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
Ubiquitination and Metabolic Disease
Meilin Ma1, Rong Cao1, Yan Tian1
1Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan, China.
Disruption of protein homeostasis, particularly through impaired ubiquitination, significantly contributes to metabolic diseases like obesity, type 2 diabetes, and NAFLD. Targeting ubiquitination pathways offers a promising therapeutic strategy for these conditions.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Disease Research
Background:
- Metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) are globally prevalent health concerns.
- Disrupted cellular protein homeostasis is a key factor in the development of these metabolic diseases.
- The ubiquitin proteasome system (UPS) is critical for maintaining cellular homeostasis by degrading aberrant proteins.
Purpose of the Study:
- To summarize the role of ubiquitination in the pathogenesis of metabolic diseases.
- To discuss the involvement of ubiquitination in obesity, T2DM, and NAFLD.
- To explore the potential of ubiquitination as a therapeutic target.
Main Methods:
- Literature review and synthesis of existing research on ubiquitination and metabolic diseases.
- Analysis of evidence linking UPS dysregulation to metabolic derangements in various tissues.
- Discussion of therapeutic strategies targeting ubiquitination pathways.
Main Results:
- Dysregulation of ubiquitination exacerbates metabolic disorders in tissues like the liver, skeletal muscle, pancreas, and adipose tissue.
- Impaired protein homeostasis due to UPS dysfunction is implicated in the initiation and progression of metabolic diseases.
- Evidence suggests a strong connection between ubiquitination processes and the pathophysiology of obesity, T2DM, and NAFLD.
Conclusions:
- Ubiquitination plays a crucial role in the pathogenesis of major metabolic diseases.
- Targeting the ubiquitin proteasome system presents a potential therapeutic avenue for managing obesity, T2DM, and NAFLD.
- Further research into ubiquitination mechanisms could lead to novel treatment strategies.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulation of Metabolism
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

